First Solar stock price: FSLR ends week at $242 after Citi shifts top pick — what to watch next

First Solar stock price: FSLR ends week at $242 after Citi shifts top pick — what to watch next

New York, Jan 24, 2026, 20:12 EST — Market closed.

  • First Solar shares gained 1.03% to close at $242.15 on Friday, still roughly 15% off their 52-week peak.
  • In a note dated Jan. 22, Citi swapped out First Solar for Generac as its leading renewables pick, The Fly’s tracker shows.

First Solar Inc (FSLR.O) shares closed Friday up 1.03%, finishing at $242.15 after trading in a range from $237.92 to $246.40. Investors digested new broker notes while gearing up for the upcoming earnings season.

Citi’s change in preference comes at a sensitive time for the stock. Investors want clearer insight into 2026 volumes and costs, and whether management can stick to guidance matching what analysts have baked into their models.

Tariffs and trade rules remain entrenched in the background, with no signs of easing. At Davos on Thursday, Tesla CEO Elon Musk commented, “Unfortunately, the tariff barriers for solar are extremely high and that makes the economics of deploying solar artificially high.” Reuters

Bank of America cut its price target to $271 from $291 but maintained a buy rating, The Fly reported.

First Solar announced earlier this week that the U.S. Patent and Trademark Office rejected three “inter partes review” petitions challenging its TOPCon patents. These petitions are a way to dispute the validity of a patent. “First Solar believes the USPTO properly exercised its discretion,” said Jason Dymbort, the company’s executive vice president and general counsel. TipRanks

Tempe, Arizona–based First Solar produces thin-film solar modules, focusing mainly on utility-scale projects. This strategy differentiates it from competitors reliant on crystalline silicon supply chains.

Legal chatter is stirring too. On Thursday, Pomerantz LLP announced it’s probing claims for First Solar investors, citing a Jan. 7 downgrade by Jefferies and the rapid stock plunge that came right after.

With U.S. markets closed until Monday, traders will be eyeing any shifts in broker forecasts for 2026 and scanning policy updates for impact on the wider solar sector. The next big catalyst? Quarterly earnings and guidance. According to Zacks’ calendar, the focus lands on Feb. 24.

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech. Her coverage ranges from stocks and technology to emerging industries and developments across global markets. She studied economics and finance at the London School of Economics and worked in market research before becoming a financial journalist. Follow Khadija Saeed on Google News.

US Stock Market Today Updates

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 Strong buy

Alphabet

NASDAQ:GOOGL 92/100 • ★★★★½
#2 Strong buy

Taiwan Semiconductor Manufacturing

NYSE:TSM 89/100 • ★★★★½
#3 Buy

S&P Global

NYSE:SPGI 88/100 • ★★★★
#4 Buy on weakness

Amazon

NASDAQ:AMZN 86/100 • ★★★★
#5 Buy on weakness

Microsoft

NASDAQ:MSFT 84/100 • ★★★★
View full portfolio
Editorial model selection. Not personalised advice.
MARKET CALENDAR

Key Events Today

The catalysts most likely to move markets.

#1

U.S. index futures reopen at 18:00 ET

This is the clearest scheduled U.S.-market price-discovery point today and can transmit weekend news into equity-index futures before Monday's cash session.

#2

New Zealand retail sales at 18:45 ET

The Q2 retail package can move NZD and regional risk sentiment. Spillover to U.S. assets is usually secondary unless the result is unusually large.

#3

No scheduled domestic U.S. data or corporate reports

The absence of U.S. releases, earnings, IPO pricings and split events leaves fewer scheduled catalysts, increasing the relative importance of weekend headlines and positioning at the futures reopen.

View full calendar
Times and estimates may change. Verify before trading.
Roche stock price holds near a 52-week high as Jan. 29 results near — what to watch next week
Previous Story

Roche stock price holds near a 52-week high as Jan. 29 results near — what to watch next week

ImmunityBio stock tumbles after glioblastoma update; what to watch before Monday
Next Story

ImmunityBio stock tumbles after glioblastoma update; what to watch before Monday